A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
ConditionPaediatric Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorRuijin Hospital
About this trial
To investigate the feasibility of deep learning-assisted rapid silent PET/MR in pediatric applications.
Eligibility criteria
Qualifiers
Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions.
Signed and dated informed consent form
Commit to complying with the research procedures and cooperate in the implementation of the entire research process.
No gender restriction, aged between 0 and 18 years old.
Disqualifiers
Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
Patients with severe claustrophobia，epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate.
Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies.
Non-compliant person.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
35 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov